Sanofi Builds OTC Business Through Organic Growth And Bolt-Ons

Sanofi-Aventis in its latest quarter made headway toward doubling its OTC business by 2014, reporting 7.4 percent organic growth and 26.3 percent growth including acquisitions in the segment